Serreze, David V.

Aberrant type 1 immunity drives susceptibility to mucosal fungal infections.

Break, T. J., Oikonomou, V., Dutzan, N., Desai, J. V., Swidergall, M., Freiwald, T., Chauss, D., Harrison, O. J., Alejo, J., Williams, D. W., et al. (2021) · Science

Immunodeficiency and Autoimmune DisordersAntifungal resistance and susceptibility

Cited by 175

Murine MHC-Deficient Nonobese Diabetic Mice Carrying Human HLA-DQ8 Develop Severe Myocarditis and Myositis in Response to Anti–PD-1 Immune Checkpoint Inhibitor Cancer Therapy

Racine, J. J., Bachman, J. F., Zhang, J.-G., Misherghi, A., Khadour, R., Kaisar, S., Bedard, O., Jenkins, C., Abbott, A., Forte, E., et al. (2024) · The Journal of Immunology

Cancer Immunotherapy and BiomarkersViral Infections and Immunology Research

Cited by 17